Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
March-2016 Volume 4 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2016 Volume 4 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis

  • Authors:
    • Saeedeh Salimi
    • Mehrangiz Noora
    • Sima Nabizadeh
    • Mahnaz Rezaei
    • Hossain Shahraki
    • Mohammadoo-Khorassani Milad
    • Anoosh Naghavi
    • Farzaneh Farajian-Mashhadi
    • Zahra Zakeri
    • Mahnaz Sandoughi
  • View Affiliations / Copyright

    Affiliations: Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran, Department of English Language, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran, Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran
  • Pages: 355-360
    |
    Published online on: February 2, 2016
       https://doi.org/10.3892/br.2016.589
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteopontin (OPN) is a chemokine-like glycoprotein that has a prominent role in regulating inflammation and immunity. OPN polymorphisms and elevated OPN levels are associated with systemic lupus erythematosus (SLE) in several populations. The aim of present study was to evaluate the association between the OPN rs1126616 polymorphism and OPN level with SLE susceptibility. A total of 163 SLE patients and 180 age‑, gender‑ and ethnically matched controls were genotyped for the rs1126616 polymorphism by the polymerase chain reaction‑restriction fragment length polymorphism method. Serum OPN levels were assayed by the enzyme‑linked immunosorbent assay. There was no association between the OPN rs1126616 C/T polymorphism and SLE. The frequency of the OPN rs1126616 CT genotype was significantly higher in SLE patients with nephritis compared to SLE patients without nephritis and controls. Additionally, the frequency of TT genotypes was higher in SLE patients with nephritis compared to controls. The serum OPN levels were significantly higher in SLE patients compared to controls (50.6±22 vs. 35.6±15.8 ng/ml, P<0.001). Increased serum OPN levels were observed in SLE patients with lupus nephritis and joint symptoms. There was no correlation between OPN levels and the OPN rs1126616 polymorphism. The present data suggest that the CT and TT genotypes of the OPN rs1126616 polymorphism could be a risk factor for lupus nephritis. The OPN level is associated with SLE and certain SLE manifestations. However, there was no association between the OPN rs1126616 C/T polymorphism and SLE susceptibility.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Crispín JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT and Tsokos GC: Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol Med. 16:47–57. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Harley JB, Kelly JA and Kaufman KM: Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol. 28:119–130. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A and Mack TM: A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 35:311–318. 1992. View Article : Google Scholar : PubMed/NCBI

4 

Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R and Hughes J: Osteopontin - a molecule for all seasons. QJM. 95:3–13. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Christensen B, Kazanecki CC, Petersen TE, Rittling SR, Denhardt DT and Sorensen ES: Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J Biol Chem. 282:19463–19472. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Scatena M, Liaw L and Giachelli CM: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 27:2302–2309. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Weber GF, Ashkar S, Glimcher MJ and Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:509–512. 1996. View Article : Google Scholar : PubMed/NCBI

8 

Murugaiyan G, Mittal A and Weiner HL: Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol. 181:7480–7488. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Briggs TA: Osteopontin - a biomarker for organ damage in paediatric lupus? Arthritis Res Ther. 15:1102013. View Article : Google Scholar : PubMed/NCBI

10 

Wong CK, Lit LC, Tam LS, Li EK and Lam CW: Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford). 44:602–606. 2005. View Article : Google Scholar : PubMed/NCBI

11 

D'Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L, Indelicato M, Giacopelli F, Marchini M, Scorza R, et al: Two single-nucleotide polymorphisms in the 5′ and 3 ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 52:539–547. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Forton AC, Petri MA, Goldman D and Sullivan KE: An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat. 19:4592002. View Article : Google Scholar : PubMed/NCBI

13 

Xu AP, Bai J, Lü J, Liang YY, Li JG, Lai DY, Wan X and Huang HH: Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients. Chin Med J (Engl). 120:2124–2128. 2007.PubMed/NCBI

14 

Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI

15 

Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ and Cantor H: Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science. 287:860–864. 2000. View Article : Google Scholar : PubMed/NCBI

16 

El-Tanani MK: Role of osteopontin in cellular signaling and metastatic phenotype. Front Biosci. 13:4276–4284. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Weber GF and Cantor H: The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev. 7:241–248. 1996. View Article : Google Scholar : PubMed/NCBI

18 

Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H and Ashkar S: Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol. 72:752–761. 2002.PubMed/NCBI

19 

Shinohara ML, Kim JH, Garcia VA and Cantor H: Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin. Immunity. 29:68–78. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Lampe MA, Patarca R, Iregui MV and Cantor H: Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol. 147:2902–2906. 1991.PubMed/NCBI

21 

Li L, Yu XQ, Yin PD, Chen YX, Liu YG and Xu HS: OPN expression of peripheral blood mononuclear cells in systemic lupus erythematosus (SLE) and its clinical significance. Chin J Rheumatol Chin. 3:84–86. 1999.(In Chinese).

22 

Iizuka J: Relationship between osteopontin expression and autoimmune disease - analysis of osteopontin expressed in transgenic mice. Hokkaido Igaku Zasshi. 73:487–495. 1998.(In Japanese). PubMed/NCBI

23 

Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO and Niewold TB: Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun. 10:487–494. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, Jolly M, Utset TO and Niewold TB: Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011:8025812011. View Article : Google Scholar : PubMed/NCBI

25 

Xu AP, Liang YY, Lü J, Li JG and Wang Z: Association of osteopontin gene polymorphism with lupus nephritis in Chinese Han population. Nan Fang Yi Ke Da Xue Xue Bao. 27:1348–1351. 2007.(In Chinese). PubMed/NCBI

26 

Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM, Namjou B, Deshmukh H, Bruner G, Espinoza LR, et al: Osteopontin and systemic lupus erythematosus association: A probable gene-gender interaction. PLoS One. 3:e00017572008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Salimi S, Noora M, Nabizadeh S, Rezaei M, Shahraki H, Milad M, Naghavi A, Farajian-Mashhadi F, Zakeri Z, Sandoughi M, Sandoughi M, et al: Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis. Biomed Rep 4: 355-360, 2016.
APA
Salimi, S., Noora, M., Nabizadeh, S., Rezaei, M., Shahraki, H., Milad, M. ... Sandoughi, M. (2016). Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis. Biomedical Reports, 4, 355-360. https://doi.org/10.3892/br.2016.589
MLA
Salimi, S., Noora, M., Nabizadeh, S., Rezaei, M., Shahraki, H., Milad, M., Naghavi, A., Farajian-Mashhadi, F., Zakeri, Z., Sandoughi, M."Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis". Biomedical Reports 4.3 (2016): 355-360.
Chicago
Salimi, S., Noora, M., Nabizadeh, S., Rezaei, M., Shahraki, H., Milad, M., Naghavi, A., Farajian-Mashhadi, F., Zakeri, Z., Sandoughi, M."Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis". Biomedical Reports 4, no. 3 (2016): 355-360. https://doi.org/10.3892/br.2016.589
Copy and paste a formatted citation
x
Spandidos Publications style
Salimi S, Noora M, Nabizadeh S, Rezaei M, Shahraki H, Milad M, Naghavi A, Farajian-Mashhadi F, Zakeri Z, Sandoughi M, Sandoughi M, et al: Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis. Biomed Rep 4: 355-360, 2016.
APA
Salimi, S., Noora, M., Nabizadeh, S., Rezaei, M., Shahraki, H., Milad, M. ... Sandoughi, M. (2016). Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis. Biomedical Reports, 4, 355-360. https://doi.org/10.3892/br.2016.589
MLA
Salimi, S., Noora, M., Nabizadeh, S., Rezaei, M., Shahraki, H., Milad, M., Naghavi, A., Farajian-Mashhadi, F., Zakeri, Z., Sandoughi, M."Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis". Biomedical Reports 4.3 (2016): 355-360.
Chicago
Salimi, S., Noora, M., Nabizadeh, S., Rezaei, M., Shahraki, H., Milad, M., Naghavi, A., Farajian-Mashhadi, F., Zakeri, Z., Sandoughi, M."Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis". Biomedical Reports 4, no. 3 (2016): 355-360. https://doi.org/10.3892/br.2016.589
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team